<DOC>
	<DOCNO>NCT01159262</DOCNO>
	<brief_summary>The purpose study investigate safety , efficacy pharmacokinetics ( PK ) dexmedetomidine ( DEX ) 3 different dose level infant , age ≥28 week ≤44 week gestational age , administer load dose follow continuous infusion minimum 6 hour 24 hour neonatal intensive care unit ( NICU ) , cardiac intensive care unit ( CICU ) , pediatric intensive care unit ( PICU ) .</brief_summary>
	<brief_title>Safety , Efficacy Pharmacokinetic Study Dexmedetomidine Pediatrics Ages ≥28 Weeks ≤44 Weeks Gestational Age</brief_title>
	<detailed_description />
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>1 . Initially intubate mechanically ventilated pediatric subject intensive care set anticipate require minimum 6 hour continuous IV sedation . 2 . The ability complete PK sample blood draw . 3 . Age : subject must fit 1 follow age range screen : Preterm neonates ≥28 week &lt; 36 week , gestational age ; would constitute treatment Group I . Term neonate bear ≥36 week ≤44 week gestational age ; would constitute treatment Group II . 4 . Weight : subject 's weight time enrollment must &gt; 1000 g. 5 . Subject 's parent ( ) legal guardian ( ) has/have voluntarily sign date informed consent document approve Institutional Review Board ( IRB ) /Independent Ethics Committee ( IEC ) . 1 . Neonate subject neurological condition prohibit evaluation sedation : Diminished consciousness increase intracranial pressure . The presence catastrophic brain injury severe mental disorder would make response sedatives unpredictable and/or measurement NPASS unreliable . Subjects immobility neuromuscular disease continuous infusion neuromuscular blocking ( NMB ) agent . 2 . Subjects second degree third degree heart block unless subject pacemaker pacing wire situ . 3 . Heart rate &lt; 120 bpm prior initiation study drug . 4 . Exposure investigational drug within 30 day prior study drug administration . 5 . Previous exposure Dexmedetomidine ( DEX ) part investigational study . 6 . Maternal history polysubstance drug abuse , base upon presence 1 ) abnormal urine drug screen cocaine , opiates and/or benzodiazepine ; 2 ) Investigator 's judgment . 7 . At discretion Investigator , subject risk DEX treatment expect exceed benefit . 8 . Subjects know allergy contraindication fentanyl , morphine , Midazolam , DEX , α2 agonist . 9 . Requirement medication DEX , Midazolam , morphine , fentanyl sedation pain control . 10 . Screening alanine aminotransferase ( ALT ) level &gt; 115 U/L .</criteria>
	<gender>All</gender>
	<minimum_age>28 Weeks</minimum_age>
	<maximum_age>44 Weeks</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Initially intubate mechanically ventilated neonate</keyword>
</DOC>